Clinical Trial Update: Pulmicort Asthma Prevention (Post-PAC) [NA]

View source ↗

Summary

The Pulmicort asthma prevention trial (Post-PAC) sponsored by AstraZeneca has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Pulmicort (budesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | NA | Status: COMPLETED